Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis

被引:48
作者
Milman, N [1 ]
Hoffmann, AL
Byg, KE
机构
[1] Naestved Hosp, Dept Pulm Med, DK-4700 Naestved, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, Dept Paediat, Copenhagen, Denmark
关键词
sarcoidosis children; sarcoidosis clinical presentation; sarcoidosis diagnosis; sarcoidosis epidemiology; sarcoidosis review; sarcoidosis treatment;
D O I
10.1080/080352598750013662
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This paper reviews current knowledge of childhood sarcoidosis with regard to the epidemiology in Danes, clinical presentation, diagnostic procedures, treatment and prognosis. Sarcoidosis is a granulomatous disease of unknown aetiology, with multiorgan involvement. The diagnosis is confirmed by the demonstration of epitheloid cell granulomas in tissue biopsy specimens. During the period 1980-92, three cases of childhood sarcoidosis were recorded in Copenhagen County, which has a total population of 610,000. The approximate incidence of clinically recognized sarcoidosis in Danish children younger than 15 y of age was 0.22-0.27/100,000 children per year, corresponding to approximately three new cases in Denmark each year. The true incidence is unknown, since the disease is often asymptomatic and resolves without a clinical diagnosis being made. In children younger than 5 y of age, the disease is characterized by involvement of skin, eyes and joints, whereas in older children involvement of lungs, lymph nodes and eyes predominate. The mainstay of treatment consists of oral corticosteroids. The risk/benefit ratio of using long-term corticosteroids needs to be evaluated in each individual patient. Some patients may benefit from additional therapy with methotrexate. The long-term prognosis is not well established, but it seems to be poorer in children younger than 5 y. Older children appear to have as favourable a prognosis as young adults.
引用
收藏
页码:871 / 878
页数:8
相关论文
共 57 条
  • [1] THE EFFECT OF CORTICOSTEROID OR METHOTREXATE THERAPY ON LUNG LYMPHOCYTES AND MACROPHAGES IN SARCOIDOSIS
    BAUGHMAN, RP
    LOWER, EE
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (06): : 1268 - 1271
  • [2] Baughman RP, 1997, SARCOIDOSIS VASC DIF, V14, P121
  • [3] BENETEAUBURNAT B, 1990, CLIN CHEM, V36, P344
  • [4] Boros D L, 1986, Clin Dermatol, V4, P10, DOI 10.1016/0738-081X(86)90030-1
  • [5] PULMONARY SARCOIDOSIS IN CHILDREN - SERIAL EVALUATION OF BRONCHOALVEOLAR LAVAGE CELLS DURING CORTICOSTEROID TREATMENT
    CHADELAT, K
    BACULARD, A
    GRIMFELD, A
    TOURNIER, G
    BOULE, M
    BOCCONGIBOD, L
    CLEMENT, A
    [J]. PEDIATRIC PULMONOLOGY, 1993, 16 (01) : 41 - 47
  • [6] A CONTROLLED-STUDY OF OXYGEN METABOLITE RELEASE BY ALVEOLAR MACROPHAGES FROM CHILDREN WITH INTERSTITIAL LUNG-DISEASE
    CLEMENT, A
    CHADELAT, K
    MASLIAH, J
    HOUSSET, B
    SARDET, A
    GRIMFELD, A
    TOURNIER, G
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (06): : 1424 - 1428
  • [7] CRONIN CC, 1990, POSTGRAD MED J, V74, P307
  • [8] HEPATIC SARCOIDOSIS - CLINICOPATHOLOGICAL FEATURES IN 100 PATIENTS
    DEVANEY, K
    GOODMAN, ZD
    EPSTEIN, MS
    ZIMMERMAN, HJ
    ISHAK, KG
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (12) : 1272 - 1280
  • [9] CORTICOSTEROIDS IN SARCOIDOSIS - FRIEND OR FOE
    DUBOIS, RM
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (07) : 1203 - 1209
  • [10] FLEMING HA, 1988, SARCOIDOSIS OTHER GR, P18